1
|
Poussin C, Titz B, Xiang Y, Baglia L, Berg R, Bornand D, Choukrallah MA, Curran T, Dijon S, Dossin E, Dulize R, Etter D, Fatarova M, Medlin LF, Haiduc A, Kishazi E, Kolli AR, Kondylis A, Kottelat E, Laszlo C, Lavrynenko O, Eb-Levadoux Y, Nury C, Peric D, Rizza M, Schneider T, Guedj E, Calvino F, Sierro N, Guy P, Ivanov NV, Picavet P, Spinelli S, Hoeng J, Peitsch MC. Blood and urine multi-omics analysis of the impact of e-vaping, smoking, and cessation: from exposome to molecular responses. Sci Rep 2024; 14:4286. [PMID: 38383592 PMCID: PMC10881465 DOI: 10.1038/s41598-024-54474-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/19/2023] [Accepted: 02/12/2024] [Indexed: 02/23/2024] Open
Abstract
Cigarette smoking is a major preventable cause of morbidity and mortality. While quitting smoking is the best option, switching from cigarettes to non-combustible alternatives (NCAs) such as e-vapor products is a viable harm reduction approach for smokers who would otherwise continue to smoke. A key challenge for the clinical assessment of NCAs is that self-reported product use can be unreliable, compromising the proper evaluation of their risk reduction potential. In this cross-sectional study of 205 healthy volunteers, we combined comprehensive exposure characterization with in-depth multi-omics profiling to compare effects across four study groups: cigarette smokers (CS), e-vapor users (EV), former smokers (FS), and never smokers (NS). Multi-omics analyses included metabolomics, transcriptomics, DNA methylomics, proteomics, and lipidomics. Comparison of the molecular effects between CS and NS recapitulated several previous observations, such as increased inflammatory markers in CS. Generally, FS and EV demonstrated intermediate molecular effects between the NS and CS groups. Stratification of the FS and EV by combustion exposure markers suggested that this position on the spectrum between CS and NS was partially driven by non-compliance/dual use. Overall, this study highlights the importance of in-depth exposure characterization before biological effect characterization for any NCA assessment study.
Collapse
Affiliation(s)
- Carine Poussin
- PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland
| | - Bjoern Titz
- PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland
| | - Yang Xiang
- PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland.
| | - Laurel Baglia
- University of Rochester Medical Center, Rochester, NY, USA
| | - Rachel Berg
- University of Rochester Medical Center, Rochester, NY, USA
| | - David Bornand
- PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland
| | | | - Timothy Curran
- University of Rochester Medical Center, Rochester, NY, USA
| | - Sophie Dijon
- PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland
| | - Eric Dossin
- PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland
| | - Remi Dulize
- PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland
| | - Doris Etter
- PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland
| | - Maria Fatarova
- PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland
| | - Loyse Felber Medlin
- PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland
| | - Adrian Haiduc
- PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland
| | - Edina Kishazi
- PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland
| | - Aditya R Kolli
- PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland
| | - Athanasios Kondylis
- PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland
| | - Emmanuel Kottelat
- PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland
| | - Csaba Laszlo
- PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland
| | - Oksana Lavrynenko
- PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland
| | - Yvan Eb-Levadoux
- PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland
| | - Catherine Nury
- PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland
| | - Dariusz Peric
- PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland
| | - Melissa Rizza
- PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland
| | - Thomas Schneider
- PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland
| | - Emmanuel Guedj
- PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland
| | - Florian Calvino
- PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland
| | - Nicolas Sierro
- PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland
| | - Philippe Guy
- PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland.
| | - Nikolai V Ivanov
- PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland.
| | - Patrick Picavet
- PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland
| | | | - Julia Hoeng
- PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland
| | - Manuel C Peitsch
- PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland
| |
Collapse
|
2
|
Iskandar AR, Kolli AR, Giralt A, Neau L, Fatarova M, Kondylis A, Torres LO, Majeed S, Merg C, Corciulo M, Trivedi K, Guedj E, Frentzel S, Calvino F, Guy PA, Ivanov NV, Peitsch MC, Hoeng J. Assessment of in vitro kinetics and biological impact of nebulized trehalose on human bronchial epithelium. Food Chem Toxicol 2021; 157:112577. [PMID: 34563633 DOI: 10.1016/j.fct.2021.112577] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/03/2021] [Revised: 08/16/2021] [Accepted: 09/18/2021] [Indexed: 11/26/2022]
Abstract
Trehalose is added in drug formulations to act as fillers or improve aerosolization performance. Its characteristics as a carrier molecule have been explored; however, the fate of trehalose in human airway tissues has not been thoroughly investigated. Here, we investigated the fate of nebulized trehalose using in vitro human air-liquid bronchial epithelial cultures. First, a tracing experiment was conducted using 13C12-trehalose; we measured trehalose distribution in different culture compartments (apical surface liquid, epithelial culture, and basal side medium) at various time points following acute exposure to 13C12-labeled trehalose. We found that 13C12-trehalose was metabolized into 13C6-glucose. The data was then used to model the kinetics of trehalose disappearance from the apical surface of bronchial cultures. Secondly, we evaluated the potential adverse effects of nebulized trehalose on the bronchial cultures after they were acutely exposed to nebulized trehalose up to a level just below its solubility limit (50 g/100 g water). We assessed the ciliary beating frequency and histological characteristics. We found that nebulized trehalose did not lead to marked alteration in ciliary beating frequency and morphology of the epithelial cultures. The in vitro testing approach used here may enable the early selection of excipients for future development of inhalation products.
Collapse
Affiliation(s)
- Anita R Iskandar
- Philip Morris International R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland.
| | - Aditya Reddy Kolli
- Philip Morris International R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland.
| | - Albert Giralt
- Philip Morris International R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland.
| | - Laurent Neau
- Philip Morris International R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland.
| | - Maria Fatarova
- Philip Morris International R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland.
| | - Athanasios Kondylis
- Philip Morris International R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland.
| | - Laura Ortega Torres
- Philip Morris International R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland.
| | - Shoaib Majeed
- Philip Morris International R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland.
| | - Celine Merg
- Philip Morris International R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland.
| | - Maica Corciulo
- Philip Morris International R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland.
| | - Keyur Trivedi
- Philip Morris International R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland.
| | - Emmanuel Guedj
- Philip Morris International R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland.
| | - Stefan Frentzel
- Philip Morris International R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland.
| | - Florian Calvino
- Philip Morris International R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland.
| | - Philippe Alexandre Guy
- Philip Morris International R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland.
| | - Nikolai V Ivanov
- Philip Morris International R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland.
| | - Manuel C Peitsch
- Philip Morris International R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland.
| | - Julia Hoeng
- Philip Morris International R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland.
| |
Collapse
|
3
|
Tolosa-Delgado A, Agramunt J, Ahn DS, Algora A, Baba H, Bae S, Brewer NT, Caballero Folch R, Calvino F, Coleman-Smith PJ, Cortes G, Davinson T, Dillmann I, Domingo-Pardo C, Estrade A, Fukuda N, Go S, Griffin CJ, Grzywacz R, Ha J, Hall O, Harkness-Brennan L, Isobe T, Kahl D, Kiss GG, Kogimtzis M, Kubono S, Labiche M, Lazarus I, Lee J, Liu J, Lorusso G, Matsui K, Miernik K, Montes F, Moon B, Morales A, Nepal N, Nishimura S, Page RD, Phong VH, Podolyak Z, Pucknell VFE, Rasco BC, Regan P, Riego A, Rubio B, Rykaczewski K, Saito Y, Sakurai H, Shimizu Y, Simpson J, Söderström PA, Stracener DW, Sumikama T, Suzuki H, Tain JL, Takechi M, Takeda H, Tarifeño-Saldivia A, Thomas SL, Woods P. Commissioning of the BRIKEN beta-delayed neutron detector for the study of exotic neutron-rich nuclei. EPJ Web Conf 2017. [DOI: 10.1051/epjconf/201716501051] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
4
|
Diakaki M, Audouin L, Berthoumieux E, Calviani M, Colonna N, Dupont E, Duran I, Gunsing F, Leal-Cidoncha E, Le Naour C, Leong L, Mastromarco M, Paradela C, Tarrio D, Tassan-Got L, Aerts G, Altstadt S, Alvarez H, Alvarez-Velarde F, Andriamonje S, Andrzejewski J, Badurek G, Barbagallo M, Baumann P, Becares V, Becvar F, Belloni F, Berthier B, Billowes J, Boccone V, Bosnar D, Brugger M, Calvino F, Cano-Ott D, Capote R, Carrapiço C, Cennini P, Cerutti F, Chiaveri E, Chin M, Cortes G, Cortes-Giraldo M, Cosentino L, Couture A, Cox J, David S, Dillmann I, Domingo-Pardo C, Dressler R, Dridi W, Eleftheriadis C, Embid-Segura M, Ferrant L, Ferrari A, Finocchiaro P, Fraval K, Fujii K, Furman W, Ganesan S, Garcia A, Giubrone G, Gomez-Hornillos M, Goncalves I, Gonzalez-Romero E, Goverdovski A, Gramegna F, Griesmayer E, Guerrero C, Gurusamy P, Haight R, Heil M, Heinitz S, Igashira M, Isaev S, Jenkins D, Jericha E, Kadi Y, Kaeppeler F, Karadimos D, Karamanis D, Kerveno M, Ketlerov V, Kivel N, Kokkoris M, Konovalov V, Krticka M, Kroll J, Lampoudis C, Langer C, Lederer C, Leeb H, Lo Meo S, Losito R, Lozano M, Manousos A, Marganiec J, Martinez T, Marrone S, Massimi C, Mastinu P, Mendoza E, Mengoni A, Milazzo P, Mingrone F, Mirea M, Mondelaers W, Moreau C, Mosconi M, Musumarra A, O’Brien S, Pancin J, Patronis N, Pavlik A, Pavlopoulos P, Perkowski J, Perrot L, Pigni M, Plag R, Plompen A, Plukis L, Poch A, Pretel C, Praena J, Quesada J, Rauscher T, Reifarth R, Riego A, Roman F, Rudolf G, Rubbia C, Rullhusen P, Salgado J, Santos C, Sarchiapone L, Sarmento R, Saxena A, Schillebeeckx P, Schmidt S, Schumann D, Stephan C, Tagliente G, Tain J, Tavora L, Terlizzi R, Tsinganis A, Valenta S, Vannini G, Variale V, Vaz P, Ventura A, Versaci R, Vermeulen M, Villamarin D, Vincente M, Vlachoudis V, Vlastou R, Voss F, Wallner A, Walter S, Ware T, Weigand M, Weiß C, Wiesher M, Wisshak K, Wright T, Zugec P. Towards the high-accuracy determination of the238U fission cross section at the threshold region at CERN – n_TOF. EPJ Web of Conferences 2016. [DOI: 10.1051/epjconf/201611102002] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
5
|
Leong L, Tassan-Got L, Tarrio D, Audouin L, Paradela C, Duran I, Le Naour C, Altstadt S, Andrzejewsky J, Barbagallo M, Bécares V, Bečvář F, Belloni F, Berthoumieux E, Billowes J, Boccone V, Bosnar D, Brugger M, Calvino F, Calviani M, Cano-Ott D, Carrapiço C, Cerutti F, Chiaveri E, Chin M, Colonna N, Cortés G, Cortés-Giraldo M, Diakaki M, Domingo-Pardo C, Dressler R, Dzysiuk N, Eleftheriadis C, Ferrari A, Fraval K, Ganesan S, García A, Giubrone G, Gómez-Hornillos M, Gonçalves I, González-Romero, Griesmayer E, Guerrero C, Gunsing F, Gurusamy P, Jenkins D, Jericha E, Kadi E, Käppeler F, Karadimos D, Kivel N, Koehler P, Kokkoris M, Korschinek G, Kroll J, Krtička M, Langer C, Lederer C, Leeb H, Losito R, Manousos A, Marganiec J, Massimi C, Martínez T, Mastinu P, Mastromarco M, Meaze M, Mengon A, Mendoza E, Milazzo P, Mingrone T, Mirea M, Mondelaers W, Pavlik A, Perkowski J, Pignatari M, Plompen A, Praena J, Quesada J, Rauscher T, Reifhart R, Riego A, Roman F, Rubbia C, Sarmento R, Schillebeeckx P, Schmidt S, Schumann D, Taín J, Tagliente G, Tsinganis A, Valenta S, Vannini G, Variale V, Vaz P, Ventura A, Versaci R, Vermeulen M, Vlachoudis V, Vlastou V, Wallner A, Ware T, Weigand M, Weiß C, Wright T, Zǔgec. Angular distribution in the neutron-induced fission of actinides. EPJ Web of Conferences 2013. [DOI: 10.1051/epjconf/20136208003] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
6
|
Campisi G, Calvino F, Carinci F, Matranga D, Carella M, Mazzotta M, Rubini C, Panzarella V, Santarelli A, Fedele S, Lo Muzio L. Peri-Tumoral Inflammatory Cell Infiltration in OSCC: A Reliable Marker of Local Recurrence and Prognosis? An Investigation Using Artificial Neural Networks. Int J Immunopathol Pharmacol 2011; 24:113-20. [DOI: 10.1177/03946320110240s220] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023] Open
Abstract
The presence of inflammatory reaction in peri-tumoural connective tissue is generally considered as a defense mechanism against cancer, but inflammation tissue in malignant transformation and early steps of oncogenesis has been recently proven to play a supporting and aggravating role in some carcinomas. Aims of this retrospective study were to evaluate in OSCCs the independent association of peri-tumoral inflammatory infiltrate (PTI) with local recurrence (LR) or survival outcome, and to verify whether PTI can be considered a marker of prognosis. Data from 211 cases of OSCC, only surgically treated between 1990 and 2000, were collected and retrospectively analyzed for PTI and the event LR (5 yrs follow-up at least) by means of univariate-multivariate and neural networks analyses. Patients (mean age 65.3 ± 12.4 yrs, M/F = 2.98) showed presence of PTI in 68.2% (144/211): (+) in 27.0%, (++) in 25.6%, (+++) 15.6%; PTI was found reduced in 24.7% of cases and absent in 7.1%. In overall PTI+ve group (n=144), 66 were TNM Stage I, 33 Stage II, 45 Stage III, none Stage IV. LR (mean 6 ± 4 months) was present in 87/211 (41.2%) patients, of which 43/144 (29.8%) in OSCCs with PTI [23 (+),. 13 (++) and 7 (+++)] vs. 44/67 (65.7%) in OSCC with PTI -/+ or PTI–ve ones. By univariate analysis, PTI+ve cases showed a significant lower risk to have LR (p<0.0001; OR= 0.2297; CI= 0.1277:0.4134) vs PTI -/+ or –ve ones, especially among cases with higher PTI value (+++) (OR= 0.1718; CI= 0.0749:03939). Multivariate analyses (Logit model and neural networks) confirmed the same datum: presence of PTI was an independent predictive variable accounting for a better tumoural outcome without LR (Logit and neural networks values: OR' 0.226; CI= 0.113:0.454; ROC Area = 0.66, respectively). In terms of prognostic significance, elevated PTI was found to have an independent association with the poorest overall survival rate (P = 0.056). Our findings strongly suggest the importance to investigate routinely PTI in OSCCs, as useful marker of tumoral behavior and prognosis, and warrant further studies on its specific cellular nature.
Collapse
Affiliation(s)
- G. Campisi
- Section of Oral Medicine “V. Margiotta”, Department of Surgical and Oncological Sciences, University of Palermo, Palermo, Italy
| | - F. Calvino
- Section of Oral Medicine “V. Margiotta”, Department of Surgical and Oncological Sciences, University of Palermo, Palermo, Italy
| | - F. Carinci
- Department of D.M.C.C.C., Section of Maxillofacial and Plastic Surgery, University of Ferrara, Ferrara, Italy
| | - D. Matranga
- Deptartment of Biopathology and Medical and Forensic Biotechnologies, University of Palermo, Italy
| | - M. Carella
- Department of Surgical Sciences, University of Foggia, Foggia, Italy
| | - M. Mazzotta
- IRCCS CROB, Centro di Riferimento Oncologico di Basilicata, Rionero in Vulture, Potenza, Italy
| | - C. Rubini
- Department of Neuroscience, Politecnica University of Marche, Ancona, Italy
| | - V. Panzarella
- Section of Oral Medicine “V. Margiotta”, Department of Surgical and Oncological Sciences, University of Palermo, Palermo, Italy
| | - A. Santarelli
- Department of Surgical Sciences, University of Foggia, Foggia, Italy
| | - S. Fedele
- UCL Eastman Dental Institute, London, United Kingdom
| | - L. Lo Muzio
- Department of Surgical Sciences, University of Foggia, Foggia, Italy
- IRCCS CROB, Centro di Riferimento Oncologico di Basilicata, Rionero in Vulture, Potenza, Italy
| |
Collapse
|
7
|
Compilato D, Carroccio A, Calvino F, Di Fede G, Campisi G. Haematological deficiencies in patients with recurrent aphthosis. J Eur Acad Dermatol Venereol 2009; 24:667-73. [DOI: 10.1111/j.1468-3083.2009.03482.x] [Citation(s) in RCA: 30] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
8
|
Campisi G, Di Liberto C, Iacono G, Compilato D, Di Prima L, Calvino F, Di Marco V, Lo Muzio L, Sferrazza C, Scalici C, Craxì A, Carroccio A. Oral pathology in untreated coeliac [corrected] disease. Aliment Pharmacol Ther 2007; 26:1529-36. [PMID: 17919276 DOI: 10.1111/j.1365-2036.2007.03535.x] [Citation(s) in RCA: 34] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
Abstract
BACKGROUND Many coeliac disease patients with atypical symptoms remain undiagnosed. AIM To examine the frequency of oral lesions in coeliac disease patients and to assess their usefulness in making coeliac disease diagnosis. PATIENTS AND METHODS One hundred and ninety-seven coeliac disease patients and 413 controls were recruited and the oral examination was performed. RESULTS Forty-six out of 197 coeliac disease patients (23%) were found to have enamel defects vs. 9% in controls (P < 0.0001). Clinical delayed eruption was observed in 26% of the pediatric coeliac disease patients vs. 7% of the controls (P < 0.0001). The prevalence of oral soft tissues lesions was 42% in the coeliac disease patients and 2% in controls (P < 0.0001). Recurrent aphthous stomatitis disappeared in 89% of the patients after 1 year of gluten-free diet. Multi-logistic analysis selected the following variables as the most meaningful in coeliac disease patients: dental enamel defects (OR = 2.652 CI = 1.427-4.926) and soft tissue lesions (OR = 41.667, CI = 18.868-90.909). Artificial Neural Networks methodology showed that oral soft tissue lesions have sensitivity = 42%, specificity = 98% and test accuracy = 83% in coeliac disease diagnosis. CONCLUSIONS The overall prevalence of oral soft tissue lesions was higher in coeliac disease patients (42%) than in controls. However, the positive-predictive value of these lesions for coeliac disease diagnosis was low.
Collapse
Affiliation(s)
- G Campisi
- Oral Sciences, University Hospital of Palermo, Palermo, Italy
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
9
|
Campisi G, Giovannelli L, Calvino F, Matranga D, Colella G, Di Liberto C, Capra G, Leao JC, Lo Muzio L, Capogreco M, D'Angelo M. HPV infection in relation to OSCC histological grading and TNM stage. Evaluation by traditional statistics and fuzzy logic model. Oral Oncol 2006; 42:638-45. [PMID: 16483833 DOI: 10.1016/j.oraloncology.2005.11.007] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/06/2005] [Accepted: 11/10/2005] [Indexed: 11/22/2022]
Abstract
We aimed to evaluate if in oral squamous cell carcinoma (OSCC) there is a relationship between histological grading (HG), TNM clinical stage and HPV infection; and to study the performance of fuzzy logic compared to traditional statistics, in the analysis of HPV status and correlates of OSCC. In cross-sectional analysis, the study group comprised 63 patients (mean age 68.89 years (SD +/-11.78), range (32-93); males 28 (44.4%), females 35 (55.6%)) with OSCC histologically diagnosed. HPV-DNA was studied in exfoliated oral epithelial cells by nested PCR (MY09/MY11 and GP5+/GP6+ primers). Data were analysed in parallel by traditional statistics with multivariate analysis and a fuzzy logic (FL) technique (membership functions as input, the ANFIS methodology, and the Sugeno's model of first order). HPV infection was detected in 24/63 (38.1%) of OSCC, as being HPV+ve 14/36 (38.9%) in G1, 7/18 (38.9%) in G2, and 3/9 (33.3%) in G3; HPV+ve 8/33 (24.2%) in Stage I, 9/12 (75.0%) in Stage II, 6/11(54.5%) in Stage III, and 1/7 (14.3%) in Stage IV. In both methods of analysis, no significantly increased risk of HPV infection was found for any HG score; whereas, TNM stage II was significantly associated to HPV infection (p=0.004; OR=9.375 (95% CI=2.030:43.30); OR'=11.148 (95% CI=1.951:43.30)), and, in particular, to primary tumour size T2 (p=0.0036; OR=7.812 (95% CI=1.914:31.890); OR'=9.414 (95% CI=1.846:48.013)); FL (% of prevision: 79.8; Root Mean-Square Error (RMSE): 0.29). No association was found between HPV infection and any demographical variable. Our findings show an association between HPV infection with TNM (stage II-T2), but not with histological grading of OSCC. Also, FL seems to be an additional effective tool in analysing the relationship of HPV infection with correlates of OSCC.
Collapse
Affiliation(s)
- G Campisi
- Dipartimento di Scienze Stomatologiche, Università di Palermo, Via del Vespro 129, 90127 Palermo, Italy.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
10
|
Gomez-Cadenas JJ, Heusch CA, Abrams G, Adolphsen CE, Akerlof C, Alexander JP, Alvarez M, Amidei D, Baden AR, Ballam J, Barish BC, Barklow T, Barnett BA, Bartelt J, Blockus D, Bonvicini G, Boyarski A, Boyer J, Brabson B, Breakstone A, Brom JM, Bulos F, Burchat PR, Burke DL, Butler F, Calvino F, Cence RJ, Chapman J, Cords D, Coupal DP, DeStaebler HC, Dorfan DE, Dorfan JM, Drell PS, Feldman GJ, Fernandez E, Field RC, Ford WT, Fordham C, Frey R, Fujino D, Gan KK, Gidal G, Gladney L, Glanzman T, Gold MS, Goldhaber G, Golding L, Green A, Grosse-Wiesmann P, Haggerty J, Hanson G, Harr R, Harris FA, Hawkes CM, Hayes K, Herrup D, Himel T, Hoenk M, Hollebeek RJ, Hutchinson D, Hylen J, Innes WR, Jaffre M. Search for elastic nondiagonal lepton-pair production in e+e- annihilation at sqrt s =29 GeV. Phys Rev Lett 1991; 66:1007-1010. [PMID: 10043972 DOI: 10.1103/physrevlett.66.1007] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/23/2023]
|
11
|
Grindhammer G, Hylen J, Harral B, Hearty C, Labarga L, Matthews J, Schaad M, Abrams G, Adolphsen CE, Akerlof C, Alexander JP, Alvarez M, Baden AR, Ballam J, Barish BC, Barklow T, Barnett BA, Bartelt J, Blockus D, Bonvicini G, Boyarski A, Boyer J, Brabson B, Breakstone A, Brom JM, Bulos F, Burchat PR, Burke DL, Butler F, Calvino F, Cence RJ, Chapman J, Cords D, Coupal DP, DeStaebler HC, Dorfan DE, Dorfan JM, Drell PS, Feldman GJ, Fernandez E, Field RC, Ford WT, Fordham C, Frey R, Fujino D, Gan KK, Gidal G, Glanzman T, Goldhaber G, Green A, Grosse-Wiesmann P, Haggerty J, Hanson G, Harr R, Harris FA, Hawkes CM, Hayes K, Herrup D, Heusch CA, Himel T, Hoenk M, Hutchinson D. Measurement of the total hadronic cross section in e+e- annihilation at sqrt s =29 GeV. Int J Clin Exp Med 1991; 43:34-45. [PMID: 10013226 DOI: 10.1103/physrevd.43.34] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
12
|
Wagner SR, Hinshaw DA, Ong RA, Snyder A, Abrams G, Adolphsen CE, Akerlof C, Alexander JP, Alvarez M, Amidei D, Baden AR, Ballam J, Barish BC, Barklow T, Barnett BA, Bartelt J, Blockus D, Bonvicini G, Boyarski A, Boyer J, Brabson B, Breakstone A, Brom JM, Bulos F, Burchat PR, Burke DL, Butler F, Calvino F, Cence RJ, Chapman J, Cords D, Coupal DP, DeStaebler HC, Dorfan DE, Dorfan JM, Drell PS, Feldman GJ, Fernandez E, Field RC, Ford WT, Fordham C, Frey R, Fujino D, Gan KK, Gidal G, Gladney L, Glanzman T, Gold MS, Goldhaber G, Green A, Grosse-Wiesmann P, Haggerty J, Hanson G, Harr R, Harris FA, Hawkes CM, Hayes K, Herrup D, Heusch CA, Himel T, Hollebeek RJ, Hutchinson D, Hylen J, Innes WR. Measurement of the B0-meson lifetime. Phys Rev Lett 1990; 64:1095-1098. [PMID: 10041298 DOI: 10.1103/physrevlett.64.1095] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/23/2023]
|
13
|
Weir AJ, Klein SR, Abrams G, Adolphsen CE, Akerlof C, Alexander JP, Alvarez M, Amidei D, Baden AR, Ballam J, Barish BC, Barklow T, Barnett BA, Bartelt J, Blockus D, Bonvicini G, Boyarski A, Boyer J, Brabson B, Breakstone A, Brom JM, Bulos F, Burchat PR, Burke DL, Butler F, Calvino F, Cence RJ, Chapman J, Cords D, Coupal DP, DeStaebler HC, Dorfan DE, Dorfan JM, Drell PS, Feldman GJ, Fernandez E, Field RC, Ford WT, Fordham C, Frey R, Fujino D, Gan KK, Gidal G, Gladney L, Glanzman T, Gold MS, Goldhaber G, Green A, Grosse-Wiesmann P, Haggerty J, Hanson G, Harr R, Harris FA, Hawkes CM, Hayes K, Herrup D, Heusch CA, Himel T, Hollebeek RJ, Hutchinson D, Hylen J, Innes WR, Jaffre M, Jaros JA. Upper limits on D+/- and B+/- decays to two leptons plus pi +/- or K+/-. Phys Rev D Part Fields 1990; 41:1384-1388. [PMID: 10012489 DOI: 10.1103/physrevd.41.1384] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/22/2023]
|
14
|
Wood DR, Petersen A, Abrams G, Adolphsen CE, Akerlof C, Alexander JP, Alvarez M, Amidei D, Baden AR, Ballam J, Barish BC, Barklow T, Barnett BA, Bartelt J, Blockus D, Bonvicini G, Boyarski A, Boyer J, Brabson B, Breakstone A, Brom JM, Bulos F, Burchat PR, Burke DL, Butler F, Calvino F, Cence RJ, Chapman J, Cords D, Coupal DP, DeStaebler HC, Dorfan DE, Dorfan JM, Drell PS, Feldman GJ, Fernandez E, Field RC, Ford WT, Fordham C, Frey R, Fujino D, Gan KK, Gidal G, Gladney L, Glanzman T, Gold MS, Goldhaber G, Golding L, Green A, Grosse-Wiesmann P, Haggerty J, Hanson G, Harr R, Harris FA, Hawkes CM, Hayes K, Herrup D, Heusch CA, Himel T, Hoenk M, Hollebeek RJ, Hutchinson D, Hylen J, Innes WR. Determination of alpha s from energy-energy correlations in e+e- annihilation at 29 GeV. Phys Rev D Part Fields 1988; 37:3091-3102. [PMID: 9958592 DOI: 10.1103/physrevd.37.3091] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/22/2023]
|
15
|
Petersen A, Abrams G, Adolphsen CE, Akerlof C, Alexander JP, Alvarez M, Amidei D, Baden AR, Ballam J, Barish BC, Barklow T, Barnett BA, Bartelt J, Blockus D, Bonvicini G, Boyarski A, Boyer J, Brabson B, Breakstone A, Brom JM, Bulos F, Burchat PR, Burke DL, Butler F, Calvino F, Cence RJ, Chapman J, Cords D, Coupal DP, DeStaebler HC, Dorfan DE, Dorfan JM, Drell PS, Feldman GJ, Fernandez E, Field RC, Ford WT, Fordham C, Frey R, Fujino D, Gan KK, Gidal G, Gladney L, Glanzman T, Gold MS, Goldhaber G, Golding L, Green A, Grosse-Wiesmann P, Haggerty J, Hanson G, Harr R, Harris FA, Hawkes CM, Hayes K, Herrup D, Heusch CA, Himel T, Hoenk M, Hollebeek RJ, Hutchinson D, Hylen J, Innes WR, Jaffre M. Multihadronic events at Ec.m. Phys Rev D Part Fields 1988; 37:1-27. [PMID: 9958515 DOI: 10.1103/physrevd.37.1] [Citation(s) in RCA: 94] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 04/12/2023]
|